Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA MedSun Focus Shifts From Recruitment To Educational Outreach

This article was originally published in The Gray Sheet

Executive Summary

FDA says that over the next year it will work to improve the quality and quantity of reports from current Medical Product Surveillance Network (MedSun) participants, rather than recruit more

You may also be interested in...



Facility inspections increase

FDA's device center exceeded facility inspection goals last year by at least 20%, according to CDRH's 1annual report for fiscal 2006. The agency conducted 1,299 domestic inspections of device firms (1,066 planned), as well as 207 foreign inspections (168 planned) and 336 bioresearch monitoring (BIMO) inspections (278 planned), the report states. The increased number of inspections is part of the center's enhanced postmarket oversight to ensure the safety and effectiveness of products, CDRH Director Dan Schultz says. The document notes that CDRH also exceeded by 15% its 2006 goal of obtaining a 71% participation rate from the 350 health care facilities participating in the Medical Product Surveillance Network (MedSun) (2"The Gray Sheet" July 25, 2006, p. 26)

Facility inspections increase

FDA's device center exceeded facility inspection goals last year by at least 20%, according to CDRH's 1annual report for fiscal 2006. The agency conducted 1,299 domestic inspections of device firms (1,066 planned), as well as 207 foreign inspections (168 planned) and 336 bioresearch monitoring (BIMO) inspections (278 planned), the report states. The increased number of inspections is part of the center's enhanced postmarket oversight to ensure the safety and effectiveness of products, CDRH Director Dan Schultz says. The document notes that CDRH also exceeded by 15% its 2006 goal of obtaining a 71% participation rate from the 350 health care facilities participating in the Medical Product Surveillance Network (MedSun) (2"The Gray Sheet" July 25, 2006, p. 26)

CDRH Tries To Move Adverse Events Into Electronic Age With eMDR Pilot

CDRH will take its first tentative steps towards electronic medical device reporting (eMDR) with a pilot program scheduled to launch this summer

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel